Thermo Fisher Scientific ($TMO) Soars with a Stellar +5.38% Weekly Gain!
For those with an eye on the TMO ticker, we present a duo of AI robots to elevate your trading experience within this domain.
-
The "Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)" AI robot shines with an impressive Annualized Return of +112%, designed to keep you at the forefront of rapid market changes and capitalize on price movements.
-
If you're keen on enduring trends, the "Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)" AI robot offers an alluring Annualized Return of +92%, potentially allowing you to ride the waves of market dynamics for optimal returns.
With these AI tools in your arsenal, you're poised to navigate the TMO landscape with precision. Let AI insights guide your trading decisions, potentially optimizing your success and amplifying your gains. Welcome to a realm of trading possibilities where AI expertise meets your aspirations.
In a week where the markets have exhibited a lot of volatility, Thermo Fisher Scientific (TMO, $555.41) emerged as a beacon of hope for many investors by clocking a notable +5.38% jump. A proud member of the Medical Specialties Industry, this rise isn't just isolated to TMO. According to A.I.dvisor's recent analysis of 499 stocks in the same industry, a significant 67.79% exhibited an uptrend this past week. 📈
However, amidst the celebrations, it's worth noting the last earnings report from July 26. TMO showcased an earnings per share of $5.15, slightly missing the estimate by $0.28. With its massive outstanding shares count of 247.56K, TMO's current market capitalization has surged to an impressive $214.36B. 💰
For dividend seekers, TMO paid out $0.35 per share with a record date on July 14, 2023. 📅 But here's something vital to remember: the ex-dividend date was on June 14, 2023. Hence, any purchases post this date won't be eligible for this dividend.
Industry Spotlight 🌟:
Medical specialties firms, including giants like Abbott Laboratories, Medtronic plc, and of course, our star performer TMO, manufacture crucial equipment for the healthcare sector. From dialysis machines, blood analysis tools to intricate surgical equipment, these companies are the backbone of modern medical infrastructure. Their strength lies in their resilience; being less sensitive to macroeconomic swings ensures a degree of stability.
Speaking numbers, the industry's average market cap stands at $6.52B. The titans in this space, like MKYSF, have valuations soaring to 3.82T, while at the other end of the spectrum, firms like FOGCF hover at 27.
Performance Highlights 📊:
- Weekly industry-wide price growth stood at 1%.
- Monthly and quarterly growth rates were -2% and 2% respectively.
- HTGMQ was the star performer with a whopping 124% growth, while GMVDF fell by a steep -55%.
Volume tells its story too: a weekly surge of 9%, contrasted by a monthly dip of -14%, and then a robust quarterly growth of 34%. Such fluctuations are indeed the heartbeat of the stock market!
Analytical Insights 🔍:
Diving deep into the fundamental metrics, here's how the industry fares:
- Valuation Rating: 50
- P/E Growth Rating: 70
- Price Growth Rating: 50
- SMR Rating: 84
- Profit Risk Rating: 87
- Seasonality Score: A slightly concerning -13
In the past five trading sessions, TMO not only gained +3.65% but did so with an average daily volume of 44,253 shares. However, a minor drawdown of -2.49% is also on the books.
🎯:
Thermo Fisher Scientific's performance has been impressive, and while the recent earnings slightly missed estimates, the company's robust fundamentals and the industry's overall trend indicate promising times ahead. As with all investments, a well-informed decision, considering all variables, is the key to success!
Stay tuned for more insights and always trade smart! 💼📈🔥
TMO in downward trend: price expected to drop as it breaks its higher Bollinger Band on August 29, 2023
TMO broke above its upper Bollinger Band on August 29, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 48 similar instances where the stock broke above the upper band. In of the 48 cases the stock fell afterwards. This puts the odds of success at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 07, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on TMO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for TMO turned negative on September 07, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
TMO moved below its 50-day moving average on September 06, 2023 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TMO crossed bearishly below the 50-day moving average on September 12, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for TMO entered a downward trend on August 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for TMO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMO advanced for three days, in of 366 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TMO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.454) is normal, around the industry mean (24.999). P/E Ratio (34.483) is within average values for comparable stocks, (80.409). Projected Growth (PEG Ratio) (1.948) is also within normal values, averaging (6.287). Dividend Yield (0.003) settles around the average of (0.018) among similar stocks. P/S Ratio (4.535) is also within normal values, averaging (59.144).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a developer of analytical and environment monitoring instruments
Industry MedicalSpecialties
TMO and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.